Download the full-sized PDF of High Performance liquid Chromatography Analysis of Nucleosides and Nucleobases in Mouse Plasma and Xenopus oocytesDownload the full-sized PDF



Permanent link (DOI):


Export to: EndNote  |  Zotero  |  Mendeley


This file is in the following communities:

Graduate Studies and Research, Faculty of


This file is in the following collections:

Theses and Dissertations

High Performance liquid Chromatography Analysis of Nucleosides and Nucleobases in Mouse Plasma and Xenopus oocytes Open Access


Other title
Mouse Plasma
Xenopus Oocytes
Type of item
Degree grantor
University of Alberta
Author or creator
Altaweraqi, Reema A
Supervisor and department
Young, James (Physiology)
Examining committee member and department
Sawyer, Michael (Medical Oncology)
Cass, Carol (Oncology)
James, Young (Physiology)
Smith, Kyla (Physiology)
Cordat, Emmanuelle (Physiology)
Department of Physiology

Date accepted
Graduation date
2017-11:Fall 2017
Master of Science
Degree level
In humans, there are three members of the cation-coupled concentrative nucleoside transporter CNT (SLC28) family, hCNT1-3: hCNT1 is selective for pyrimidine nucleosides but also transports adenosine, hCNT2 transports purine nucleosides and uridine, and hCNT3 transports both pyrimidine and purine nucleosides. hCNT1/2 transport nucleosides using the transmembrane Na+ electrochemical gradient, while hCNT3 is both Na+- and H+-coupled. By producing recombinant hCNT3 in Xenopus laevis oocytes, I used radiochemical high performance liquid chromatography (HPLC) analysis to investigate the metabolic fate of transported radiolabelled [3H] and [14C] pyrimidine and purine nucleosides inside cells. My findings suggest that transported nucleosides in oocytes after 30 minute of incubation are generally subject to minimal intracellular metabolism (uridine 7%, cytidine 0%, thymidine 0%, inosine 16% and guanosine 0%). The exception was adenosine, for which only 49% remained unmetabolized. I also used radiochemical HPLC analysis to study mechanisms by which adenosine functions as an atypical low Km, low Vmax permeant of pyrimidine nucleoside-selective hCNT1. Oocytes producing recombinant hCNT1 were pre-loaded with [3H]uridine, after which efflux of accumulated radioactivity was measured in transport medium alone, or in the presence of extracellular non-radiolabelled adenosine or uridine. The results found that hCNT1-mediated [3H]-efflux was stimulated by extracellular uridine, but inhibited by extracellular adenosine, with > 95% of the radioactivity exiting cells being unmetabolized radiolabelled uridine. This suggests that the low Vmax for adenosine transport by hCNT1 is a consequence of low transmembrane mobility of the hCNT1/adenosine complex. Humans also possess four members of the equilibrative nucleoside transporter ENT (SLC29) family, hENT1-4. hENT1 and hENT2 function to transport both nucleosides and nucleobases into and out of cells, but their relative contributions to nucleoside and nucleobase homeostasis and, in particular, to adenosine signaling via purinoreceptors, are not known. My second project addressed this question by using HPLC to compare plasma nucleoside and nucleobase concentrations in wild-type, mENT1-, mENT2- and mENT1/mENT2-knockout (KO) mice. Results from these studies demonstrated the importance of ENT1 relative to ENT2 in determining plasma adenosine concentrations, indicating a modest role of both transporters in inosine homeostasis, and suggested that neither is a major participant in handling of nucleobases.
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication
Acimovic Y & Coe IR (2002) Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol. Biol. Evol. 19, 2199-2210.Baldwin SA, Mackey JR, Cass CE & Young, JD (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol. Med. Today 5, 216-224.Baldwin SA, Beal PR, Yao SYM, King, AE, Cass CE & Young, JD (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447,735-743.Baldwin SA, Yao SYM, Hyde RJ, Ng AML, Foppolo S, Barnes K, Ritzel MWL, Cass CE & Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol. Chem. 280, 15880-15887.Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel MWL, Claycomb WC, Cass CE, Young JD, Billeter-Clark R, Boyett MR & Baldwin SA (2006) Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ. Res. 99, 510-519.Belardinelli L, Linden J & Berne RM (1989) The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32, 73-97.Bone DB, Robillard KR, Stolk M, & Hammond JR (2007) Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2. Mol. Membr. Biol. 24, 294-303. Cass CE, Young JD & Baldwin SA (1998) Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell Biol. 76, 761-770.Cass CE, Young JD & Baldwin SA (1998) Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell Biol. 76, 761-770.Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JR, Ng AM, Ritzel MW, Vickers MF & Yao SY (1999) Nucleoside transporters of mammalian cells. Pharm Biotechnol 12, 313-352.Chen J, Rinaldo L, Lim SJ, Young H, Messing, RO & Choi DS (2007) The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice. Genes Brain Behav. 6, 776-793.Choi DS, Handa M, Young H, Gordon AS, Diamond I & Messing RO (2000) Genomic organization and expression of the mouse equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene. Biochem. Biophys. Res. Commun. 277, 200-208.Coe IR, Griffiths M, Young JD, Baldwin SA & Cass CE (1997) Assignment of the human equilibrative nucleoside transporter (hENT1) to 6p21.1-p21.2. Genomics 45, 459- 460.Crawford CR, Patel DH, Naeve C & Belt JA (1998) Cloning of the human equilibrative nitrobenzylmercaptopurine ribose (NBMPR)-insensitive nucleosidetransporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. 273, 5288-5293.Damaraju VL, Damaraju S, Young JD, Baldwin SA, Mackey J, Sawyer MB & Cass CE (2003) Nucleoside anticancer drugs: the role of nucleoside transport in resistance to cancer chemotherapy. Oncogene 22, 7524-7536.Damaraju VL, Elwi AN, Hunter C, Carpenter P, Santos C, Barron GM, Sun X, Baldwin SA, Young JD, Mackey JR, Sawyer MB & Cass CE (2007) Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. Am. J. Physiol. Renal Physiol. 293, F200-F211.Dresser MJ, Gerstin KM, Gray AT, Loo DD & Giacomini KM (2000) Electrophysiological analysis of the substrate selectivity of a sodium-coupled nucleoside transporter (rCNT1) expressed in Xenopus laevis oocytes. Drug Metab. Dispos. 28, 1135-1140Elwi AN, Damaraju VL, Baldwin SA, Young JD, Sawyer MB & Cass CE (2006) Renal nucleoside transporters: physiological and clinical implications. Biochem. Cell. Biol. 84, 844-858.Gray JH, Owen RP & Giacomini KM (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447, 728-734. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nürnberg B, Haase VH, Xia Y, Sitkovsky M & Eltzschig HK (2012) Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest. 122, 693-710.Griffith DA & Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta 1286, 153-181.Griffiths M, Beaumont N, Yao SYM, Sundaram M, Bouman CE, Davies A, Kwong FYP, Coe IR, Cass CE, Young JD & Baldwin SA (1997a) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med. 3, 89-93.Griffiths M, Yao SY, Abidi F, Phillips ES, Cass CE, Young JD & Baldwin SA (1997b) Molecular cloning and characterization of a nitrobenzylthioinosine- insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. 328, 739-743.Govindarajan R, Leung GPH, Zhou MY, Tse CM, Wang J, Unadkat JD (2009) Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G910-G922.Gu JG, Foga IO, Parkinson FE & Geiger JD (1995) Involvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations. J. Neurochem. 54, 2105-2110.Guida L, Bruzzone S, Sturla L, Franco L, Zocchi E & De Flora A (2002) Equilibrative and concentrative nucleoside transporters mediate influx of extracellular cyclic ADP- Ribose into 3T3 murine fibroblasts. J. Biol. Chem. 277, 47097-47105.Hamilton SR, Yao SY, Ingram JC, Hadden DA, Ritzel MW, Gallagher MP, Henderson PJ, Cass CE, Young JD, Baldwin SA. (2001) Subcellular distribution and membrane topology of the mammalian concentrative Na+-nucleoside cotransporter rCNT1. J Biol Chem. 276, 27981-27988.Handa M, Choi DS, Caldeiro RM, Messing RO, Gordon AS & Diamond I. (2001) Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene 262, 301-307.Heydrick SJ, Lardeux BR & Mortimore GE (1991) Uptake and degradation of cytoplasmic RNA by hepatic lysosomes. Quantitative relationship to RNA turnover. J. Biol. Chem. 266, 8790-8796.Hsu CL, Lin W, Seshasayee D, Chen YH, Ding X, Lin Z, Suto E, Huang Z, Lee WP, Park H, Xu M, Sun M, Rangell L, Lutman JL, Ulufatu S, Stefanich E, Chalouni C, Sagolla M, Diehl L, Fielder P, Dean B, Balazs M & Martin F (2012) Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science. 335, 89-92.Huang QQ, Yao SY, Ritzel MWL, Paterson ARP, Cass CE & Young JD (1994) Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. 269, 17757-17760.Hyde RJ, Cass CE, Young JD & Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel informs. Mol. Membr. Biol. 18, 53-63.Ishikawa T, Kim RB, & König J (2013). Pharmacogenomics of human drug transporters: clinical impacts. Hoboken, N.J.: John Wiley & Sons.Jarvis SM & Griffith DA (1991) Expression of the rabbit intestinal N2 Na+/nucleoside transporter in Xenopus laevis ocoytes. Biochem. J. 278, 605-607.Jeffrey LW, Sherali A, Mo Z-P & Tse C-M (2000) Kinetic and pharmacological properties of cloned human Equilibrative Nucleoside Transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. J. Biol. Chem. 275, 8375-8381.Johnson, ZL, Cheong C-G and Lee S-Y (2012) Crystal structure of a concentrative nucleoside transporter from Vibrio cholera at 2.4 A. Nature. 483, 489-493.Johnson ZL, Lee J-H, Lee K, Lee M, Kwon D-Y, Hong J & Lee S-Y (2014) Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters. eLife. 3, e03604.Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA & Hammond JR (2000) Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor30 resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochemical J. 352, 363-372.Lemieux MJ, Song J, Kim MJ, Huang Y, Villa A, Auer M, Li XD, & Wang DN. (2003) Three-dimensional crystallization of the Escherichia coli glycerol-3-phosphate transporter: a member of the major facilitator superfamily. Protein Sci. 12, 2748-2756.Lang TT, Young JD & Cass CE (2004) Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line. Mol. Pharm. 65, 925-933.Larrayoz IM, Casado FJ, Pastor-Anglada M & Lostao MP (2004) Electrophysiological characterization of the human Na+/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function. J. Biol. Chem. 279, 8999-9007.Lee W, Cheeseman CI & Jarvis SM (1988) Na+- and K+-dependent uridine transport in rat renal brush-border membrane vesicles. Biochim. Biophys. Acta. 942:,139-149.Mackey JR, Baldwin SA, Young JD & Cass CE (1998) Nucleoside transport and its significance for anticancer drug resistance. Drug Resist Updat. 1,310-324.Masino, S & Boison, D (2013). Adenosine: a key link between metabolism and brain activity. New York, NY: Springer.Miller AJ & Zhou JJ (2000) Xenopus oocytes as an expression system for plant transporters. Biochimica et Biophysica Acta 1465. 343-358.Morgan NV, Morris MR, Cangul H, Gleeson D, Straatman-Iwanowska A, Davies N, Keenan S, Pasha S, Rahman F, Gentle D, Vreeswijk MP, Devilee P, Knowles MA, Ceylaner S, Trembath RC, Dalence C, Kismet E, Köseoğlu V, Rossbach HC, Gissen P, Tannahill D & Maher ER (2010) Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genet. 6, e1000833.Mubagwa K & Flameng, W (2001) Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52, 25-39.Mubagwa K, Mullane K & Flameng, W (1996) Role of adenosine in the heart and circulation. Cardiovasc. Res. 32, 797-813.Murray AW (1971) The biological significance of purine salvage. Annu. Rev. Biochem. 40, 811- 826.Niitani M, Nishida K, Okuda H, Nagai K, Fujimoto S, Nagasawa K (2010) Transport characteristics of mouse concentrative nucleoside transporter 1. Int J Pharm. 388, 168- 174.Oliver, JM & Paterson, AR (1971) Nucleoside transport. I. A mediated process in human erythrocytes. Can. J. Biochem. 49, 262-270.Parkinson FE, Damaraju VL, Graham K, Yao SY, Baldwin SA, Cass CE & Young JD (2011) Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr. Top. Med. Chem. 11, 948-972.Pastor-Anglada M & Pérez-Torras S (2015). Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets. Frontiers in Pharmacology, 6,13.Pastor-Anglada M, Felipe A & Casado FJ (1998) Transport and mode of action of nucleosides derivatives used in chemical and antiviral therapies. Trends Pharmacol. Sci. 19, 424-430.Patel D, Crawford C, Naeve C & Belt J (1997) Molecular cloning and characterization of a mouse purine-selective concentrative nucleoside transporter. Proc. Am. Assoc. Cancer Res. 38, 60.Paterson AR & Oliver JM (1971) Nucleoside transport. II. Inhibition by pnitrobenzylthioguanosine and related compounds. Can. J. Biochem. 49, 271-274.Pennycooke M, Chaudary N, Shuralyova, I, Zhang Y & Coe IR (2001) Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem. Biophys. Res. Commun. 280, 951-959.Pisoni RL & Thoene JG (1989) Detection and characterization of a nucleoside transport sysyem in human fibroblast lysosomes. J. Biol. Chem. 264, 4850-4856.Pritchard JB, O’ Connor N, Oliver JM & Berlin RD (1975) Uptake and supply of purine compounds by the liver. Am. J. Physiol. 242, R465-R470.Ritzel MWL, Yao SYM, Huang MY, Elliot JF, Cass CE & Young, JD (1997) Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am J. Physiol. 272, C707-C714.Ritzel MW, Yao SY, Ng AM, Mackey JR, Cass CE & Young JD (1998). Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol 15, 203–211.Ritzel MWL, Ng AML, Yao SYM, Graham K, Loewn, SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen X-Z, Karpinski E, Hyde RJ, Baldwin SA, Cass CE & Young JD (2001) Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J. Biol. Chem. 276, 2914-2927.Sankar N, Machado J, Abdulla P, Hilliker AJ & Coe IR (2002) Comparative genomic analysis of equilibrative nucleoside transporters suggest conserved protein structure despite limited sequence identity. Nucleic Acids Res. 30, 433904350.Slugoski DM, Ng AML, Yao SYM, Lin CC, Mulinta R, Cass CE, Baldwin SA & Young JD (2009) Substituted Cysteine Accessibility Method Analysis of Human Concentrative Nucleoside Transporter hCNT3 Reveals a Novel Discontinous Region of Functional Inmportance within the CNT Family Motif (G/A)XKX3NEFVA(Y/M/F). J. Biol. Chem. 284, 17281-17292.Smith KM, Ng AM, Yao SYM, Labedz KA, Knauss EE, Wiebe LI, Cass CE, Baldwin SA, Chen X-Z, Karpinski E & Young, JD (2004) Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes. J. Physiol. 558, 807-823.Smith KM, Slugoski MD, Cass CE, Baldwin SA, Karpinski E & Young JD (2007) Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3. Mol. Membr. Biol. 24, 53-64.Smith KM, Slugoski MD, Loewen SK, Ng AML, Yao SYM, Chen X.-Z, Karpinski E, Cass CE., Baldwin SA & Young JD (2005) The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics. J. Biol. Chem. 280, 25436-25449.Sobczak K, Bangel-Ruland N, Leier G, Weber WM (2010) Endogenous transport systems in the Xenopus laevis oocyte plasma membrane. Methods. 51, 183-189.Szkotak AJ, Ng AL, Sawicka J, Baldwin SA, Man SP, Cass CE, Young JD & Duszyk M (2001) Regulation of K+ current in human airway epithelial cells by exogenous and autocrine adenosine. Am. J. Physiol. 281, C1991-C2002.Tattersall, MHN., Slowiaczek, P & De Fazio, A (1983) Regional variation in human extracellular purine levels. J. Lab. Clin. Med. 102, 411-420.

File Details

Date Uploaded
Date Modified
Audit Status
Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 2206429
Last modified: 2017:11:08 18:12:20-07:00
Filename: Altaweraqi_Reema_A_201705_MSc-2 copy.pdf
Original checksum: cb4ac2ca766bd441b1ff8a3228216d59
Well formed: true
Valid: true
File title: Reema_thesis-title-page (final corrections)
File author: gracet
Page count: 108
Activity of users you follow
User Activity Date